Cargando…

Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia

We assessed the clinical effectiveness and safety of CKI (compound Kushen injection) plus standard induction chemotherapy for treating adult acute leukemia (AL). We randomly assigned 332 patients with newly diagnosed AL to control (n = 165, receiving DA (daunorubicin and cytarabine) or hyper-CVAD (f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Honglei, Lei, Bo, Meng, Shan, Liu, Hailing, Wei, Yongchang, He, Aili, Zhang, Wanggang, Zhou, Fuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050378/ https://www.ncbi.nlm.nih.gov/pubmed/27738441 http://dx.doi.org/10.1155/2016/3121402

Ejemplares similares

Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway
por: Jin, Yanxia, et al.
Publicado: (2018)

Effects of compound Kushen injection on pathology and angiogenesis of tumor tissues
por: Wang, Hongyan, et al.
Publicado: (2019)

Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis
por: Dou, Dou, et al.
Publicado: (2020)

Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis
por: Shen, Hanyuan, et al.
Publicado: (2019)

Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology
por: Meng, Ziqi, et al.
Publicado: (2019)

Compound Kushen injection reduces severity of radiation-induced gastrointestinal mucositis in rats
por: Harata-Lee, Yuka, et al.
Publicado: (2022)

The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics
por: Zhang, Yiting, et al.
Publicado: (2023)

A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas
por: Jin, Yanxia, et al.
Publicado: (2019)

Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer
por: Liu, Xinkui, et al.
Publicado: (2022)

A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer
por: Li, Yi, et al.
Publicado: (2021)

The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms
por: Cui, Jian, et al.
Publicado: (2020)

Compound Kushen Injection for gastric cancer: A protocol of systematic review and meta-analysis
por: Huang, Zhihong, et al.
Publicado: (2019)

Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology
por: Zhou, Wei, et al.
Publicado: (2020)

Compound kushen injection for multiple myeloma: A protocol of systematic review and meta-analysis
por: Yang, Xinwei, et al.
Publicado: (2019)

Compound Kushen Injection Protects Skin From Radiation Injury via Regulating Bim
por: Zheng, Jianxiao, et al.
Publicado: (2021)

Antioxidant and Immunity Activities of Fufang Kushen Injection Liquid
por: Zhou, Shen-Kang, et al.
Publicado: (2012)

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
por: Cherry, Evan M., et al.
Publicado: (2021)

Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics
por: Qu, Zhipeng, et al.
Publicado: (2016)

Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer
por: Sun, Jie, et al.
Publicado: (2022)

Efficacy and safety of compound Kushen injection combined with chemotherapy on postoperative Patients with breast cancer: A meta-analysis of randomized controlled trials
por: Ao, Man, et al.
Publicado: (2019)

Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis
por: Yu, Hui-Bo, et al.
Publicado: (2023)

Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology
por: Zhou, Wei, et al.
Publicado: (2020)

Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis
por: Guo, Yu-ming, et al.
Publicado: (2015)

Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection
por: Cui, Jian, et al.
Publicado: (2019)

An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification
por: Lu, Shan, et al.
Publicado: (2022)

A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification
por: Liu, Shuyu, et al.
Publicado: (2020)

High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer
por: Liu, Xinkui, et al.
Publicado: (2021)

Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle
por: Aung, T. N., et al.
Publicado: (2019)

Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect
por: He, Ruirong, et al.
Publicado: (2020)

Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway
por: Li, Luo, et al.
Publicado: (2022)

Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking
por: Ye, Zhangpeng, et al.
Publicado: (2022)

Analysis of Risk Factors of Coagulation Dysfunction and Hemorrhage in Newly Diagnosed Hyperleukocytic Acute Myeloma Leukemia
por: Xu, Anjie, et al.
Publicado: (2022)

C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia
por: Lei, Bo, et al.
Publicado: (2017)

Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia
por: Altman, Jessica K., et al.
Publicado: (2017)

A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation
por: Wu, Chao, et al.
Publicado: (2021)

Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Yu, Lixiu, et al.
Publicado: (2017)

Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation
por: Gao, Li, et al.
Publicado: (2018)

Compound Kushen injection attenuates angiotensin II-mediated heart failure by inhibiting the PI3K/Akt pathway
por: Wang, Wei, et al.
Publicado: (2023)

A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Palmisiano, Neil, et al.
Publicado: (2023)

Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
por: Yang, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i0l2clshf6sb302ttajq272ra0